Hettie buys NEWL 0.63: Kamada : to Announce Results from Phase 2/3 Clinical Trial of Inhaled AAT to Treat Alpha-1 Antitrypsin Deficiency on May 16
03/05 KAMADA LTD.: Kamada Initiates Phase 2/3 Clinical Trial of Glassia to Treat Newl.. 03/04 KAMADA LTD.: Kamada Completes Enrollment in U.S. Pivotal Clinical Trial with Ka.. 02/24 KAMADA LTD.: Kamada to Ring The NASDAQ Stock Market Opening Bell on ... ...
47 people liked this
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home